Privia Health Group IncPRVA
▼ NegativeCapitalrelevance
Adjusted EPS missed expectations by 22.2%, causing negative market reaction despite revenue beat.
Impact on stocks 1
Health Care
Privia Health Group IncPrivia Health's second quarter results were met with a negative market reaction as investors digested the company's strong revenue growth alongside a material shortfall in non-GAAP profit relative to Wall Street expectations. Revenue came in at $632.6 million versus analyst estimates of $597.2 million, a 21.4% year-on-year increase and a 5.9% beat, while adjusted EPS of $0.19 missed analyst expectations of $0.24 by 22.2%. Adjusted EBITDA was $37.43 million versus estimates of $36.88 million, and operating margin improved to 1.9% from 0.6% a year earlier. During the earnings call, analysts questioned management on delayed CMS shared savings payments, confidence in reaching the high end of long-term EBITDA margin targets, deceleration in second-half practice collections growth, AI use cases, and integration of the Evolent and IMS acquisitions. CEO Parth Mehrotra described the guidance as prudent and highlighted AI deployment across corporate and care workflows, while CFO David Mountcastle pointed to operational leverage and market maturity as margin drivers.
Privia Health Group IncAdjusted EPS missed expectations by 22.2%, causing negative market reaction despite revenue beat.